Dr Kari Lancaster
TitleCited byYear
Illicit drugs and the media: Models of media effects for use in drug policy research
K Lancaster, CE Hughes, B Spicer, F MATTHEW‐SIMMONS, P Dillon
Drug and Alcohol Review 30 (4), 397-402, 2011
782011
Confidentiality, anonymity and power relations in elite interviewing: conducting qualitative policy research in a politicised domain
K Lancaster
International Journal of Social Research Methodology 20 (1), 93-103, 2017
732017
Producing the ‘problem of drugs’: A cross national-comparison of ‘recovery’discourse in two Australian and British reports
K Lancaster, K Duke, A Ritter
International Journal of Drug Policy 26 (7), 617-625, 2015
732015
Examining the construction and representation of drugs as a policy problem in Australia's National Drug Strategy documents 1985–2010
K Lancaster, A Ritter
International Journal of Drug Policy 25 (1), 81-87, 2014
662014
Social construction and the evidence-based drug policy endeavour
K Lancaster
International Journal of Drug Policy 25 (5), 948-951, 2014
622014
How do Australian news media depict illicit drug issues? An analysis of print media reporting across and between illicit drugs, 2003–2008
CE Hughes, K Lancaster, B Spicer
International Journal of Drug Policy 22 (4), 285-291, 2011
552011
Laws prohibiting peer distribution of injecting equipment in Australia: A critical analysis of their effects
K Lancaster, K Seear, C Treloar
International Journal of Drug Policy 26 (12), 1198-1206, 2015
402015
Public opinion and drug policy in A ustralia: Engaging the ‘affected community’
K Lancaster, A Ritter, J Stafford
Drug and Alcohol Review 32 (1), 60-66, 2013
402013
Problems, policy and politics: Making sense of Australia's ‘ice epidemic’
K Lancaster, A Ritter, H Colebatch
Policy Studies 35 (2), 147-171, 2014
382014
An assessment of illicit drug policy in Australia (1985 to 2010): Themes and trends
A Ritter, K Lancaster, K Grech, P Reuter
National Drug and Alcohol Research Centre, 2011
352011
Stigma and subjectivities: Examining the textured relationship between lived experience and opinions about drug policy among people who inject drugs
K Lancaster, L Santana, A Madden, A Ritter
Drugs: Education, Prevention and Policy 22 (3), 224-231, 2015
312015
Measuring research influence on drug policy: a case example of two epidemiological monitoring systems
A Ritter, K Lancaster
International journal of drug policy 24 (1), 30-37, 2013
312013
Performing the evidence-based drug policy paradigm
K Lancaster
Contemporary Drug Problems 43 (2), 142-153, 2016
242016
The productive techniques and constitutive effects of ‘evidence-based policy’and ‘consumer participation’discourses in health policy processes
K Lancaster, K Seear, C Treloar, A Ritter
Social Science & Medicine 176, 60-68, 2017
232017
Examining the opinions of people who use drugs towards drug policy in Australia
K Lancaster, R Sutherland, A Ritter
Drugs: education, prevention and policy 21 (2), 93-101, 2014
232014
Media reporting on illicit drugs in Australia: Trends and impacts on youth attitudes to illicit drug use
C Hughes, B Spicer, K Lancaster, F Matthew-Simmons, P Dillon
Sydney: National Drug and Alcohol Research Centre, 2010
222010
Media reporting on illicit drugs in Australia: Trends and impacts on youth attitudes to illicit drug use
C Hughes, B Spicer, K Lancaster, F Matthew-Simmons, P Dillon
Sydney: National Drug and Alcohol Research Centre, 2010
222010
The stigmatisation of ‘ice’and under-reporting of meth/amphetamine use in general population surveys: a case study from Australia
J Chalmers, K Lancaster, C Hughes
International Journal of Drug Policy 36, 15-24, 2016
212016
‘Naloxone works’: The politics of knowledge in ‘evidence-based’drug policy
K Lancaster, C Treloar, A Ritter
Health: 21 (3), 278-294, 2017
192017
A critical examination of the definition of ‘psychoactive effect’in Australian drug legislation
MJ Barratt, K Seear, K Lancaster
International Journal of Drug Policy 40, 16-25, 2017
192017
The system can't perform the operation now. Try again later.
Articles 1–20